The World Health Organization reports approximately 374 million new STI cases annually, including treatable infections such as chlamydia, gonorrhea, syphilis, and trichomoniasis. Often asymptomatic, these infections spread quickly, exacerbated by the stigma and high costs associated with traditional testing methods. Untreated, STIs can lead to severe health issues, including increased risk of HIV, infertility, and other long-term complications.<\/p>\n\n\n\n
Building on the momentum of its previous CHF 1.6 million financing round<\/a>, Testmate Health<\/a> has developed a cost-effective, over-the-counter diagnostic urine test primarily targeting chlamydia and gonorrhea\u2014two major causes of infertility. This user-friendly kit enables individuals to conduct tests privately at home, delivering results within 30 minutes and eliminating the need for clinical visits. In cases of positive results, the system connects users with healthcare professionals for immediate consultation and prescription, providing an integrated solution from diagnosis to treatment.<\/p>\n\n\n\n